News
Category: News Clear
Categories
March 24, 2025
February 5, 2025
Principal Investigator | Oncologist, Hematologist
Dr. Nguyen has been a vital asset to Lumi Research since November 2024, bringing extensive expertise and a strong commitment to expanding access to oncology trials. He currently serves as Principal Investigator (Pl) on 6 studies (including 2 non-oncology) and has a proven track record, with prior experience as an investigator on 7 additional oncology trials and a history of successful patient enrollment.
Dr. Nguyen’s passion for ensuring equitable access to cutting-edge oncology research, coupled with his multi-state board certifications, including Texas, positions him as a key driver of our clinical research initiatives.
Network Investigator | Oncologist, Hematologist
With a legacy of service to both his country and his patients, Dr. Zaleski is expanding his community oncology practice to include clinical trials. A US Navy Captain (retired) and a physician who opened his practice in 1978, Dr. Zaleski’s longstanding affiliation with The Methodist Hospital group speaks to his expertise and commitment to quality care. His initiative to integrate clinical research reflects his forward-thinking approach and his unwavering dedication to providing his patients with access to the latest advancements in cancer treatment.
Investigator | Oncologist, Hematologist
Dr. Li, a respected community oncologist with a distinguished background from MD Anderson Cancer Center, is partnering with Lumi Research to enhance patient care in Garland, Texas. Since 2002, he has been dedicated to providing personalized treatment, and now, he is expanding his services to include clinical trials. This collaboration will bring groundbreaking treatment options directly to his community, reflecting his unwavering commitment to improving patient outcomes.
Investigator | Family Medicine
Lumi Research is strengthened by the addition of Dr. Alan Tran, whose primary objective is to optimize the patient research visit experience. Leveraging his background as a former private practice owner (sold to Village Medical), Dr. Tran brings both a strategic business perspective and a commitment to clinical excellence.
He plays a vital role in coordinating with the study team and remote Principal Investigator, Dr. David Nguyen, while also providing critical clinical support through patient examinations and the management of lab and imaging orders. Dr. Tran’s contributions are essential to our research success, and his expertise continues to grow with each trial.
Chief Executive Officer, Co-Founder
Lumi Research is led by CEO Bhavin, a biochemist with a profound commitment to improving patient outcomes through expanded clinical trial access. His experience as part of the scientific team that created venetoclax underscores his dedication to medical innovation. Inspired by his entrepreneurial family, Bhavin co-founded Lumi Research in 2021 to bridge the gap between cutting-edge research and community healthcare. His vision is to strategically grow Lumi Research, enabling more patients to benefit from life-saving treatment options close to home.
Chief Technology Officer
Jonathan has worked for several years at #1 cancer center in the world, developing software to manage clinical trials. As the burden of organizational constraints grew, he moved on to work with oncology startups to help better the software used in medical institutions. He has lead software projects in several different fields with many people all over the world. Overall he has 20+ years software development and management experience.
Chief Strategy Officer
Linda is a clinical research professional with over 25 years in healthcare serving in varied progressive roles. She has a history of optimizing clinical research infrastructures, orchestrating successful multi-institutional academic clinical research consortiums, and strategic pharmaceutical collaborations designed to decrease clinical trial activation timelines, strengthen quality assurance, and reduce financial operating associated costs.
Linda has provided clinical research operations oversight experience (first in man, phase I -III protocols, immune-modulating agents) for several major academic medical centers.
Late Chief Executive Officer, Co-Founder
Mike spent several years developing what is now the world most utilized clinical trial platform at the University of Texas, MD Anderson Cancer Center. There he served as the PI for multiple trials, and streamlined more than 3500 through his clinical trial management system. Mike has passed on now, but will live in our hearts forever. In honor of Mike, on May 10, 2021 the members of PRO Research Management unanimously voted to change the name to Lumi Research to symbolize the path he lit forward for the company.
Chief Operating Officer
With 20+ years of experience in the medical field, Lauren joined Lumi with one goal in mind; to propel Lumi Research towards success. Working alongside our late CEO, she trained, developed and managed a large clinical research team and oversaw the execution of over 100 clinical trials for one of the top cancer centers in the nation. Lauren’s focus is to ensure that Lumi Research is staffed with a passionate, talented and innovative team.
Business Development Manager
Clinical Research Coordinator II
Regulatory Specialist
Clinical Research Supervisor
Sr. Clinical Research Coordinator
Clinical Trial Assistant
Research Nurse
Principal Investigator | Oncologist, Hematologist
Dr. Nguyen has been a vital asset to Lumi Research since November 2024, bringing extensive expertise and a strong commitment to expanding access to oncology trials. He currently serves as Principal Investigator (Pl) on 6 studies (including 2 non-oncology) and has a proven track record, with prior experience as an investigator on 7 additional oncology trials and a history of successful patient enrollment.
Dr. Nguyen’s passion for ensuring equitable access to cutting-edge oncology research, coupled with his multi-state board certifications, including Texas, positions him as a key driver of our clinical research initiatives.
Network Investigator | Oncologist, Hematologist
With a legacy of service to both his country and his patients, Dr. Zaleski is expanding his community oncology practice to include clinical trials. A US Navy Captain (retired) and a physician who opened his practice in 1978, Dr. Zaleski’s longstanding affiliation with The Methodist Hospital group speaks to his expertise and commitment to quality care. His initiative to integrate clinical research reflects his forward-thinking approach and his unwavering dedication to providing his patients with access to the latest advancements in cancer treatment.
Investigator | Oncologist, Hematologist
Dr. Li, a respected community oncologist with a distinguished background from MD Anderson Cancer Center, is partnering with Lumi Research to enhance patient care in Garland, Texas. Since 2002, he has been dedicated to providing personalized treatment, and now, he is expanding his services to include clinical trials. This collaboration will bring groundbreaking treatment options directly to his community, reflecting his unwavering commitment to improving patient outcomes.
Investigator | Family Medicine
Lumi Research is strengthened by the addition of Dr. Alan Tran, whose primary objective is to optimize the patient research visit experience. Leveraging his background as a former private practice owner (sold to Village Medical), Dr. Tran brings both a strategic business perspective and a commitment to clinical excellence.
He plays a vital role in coordinating with the study team and remote Principal Investigator, Dr. David Nguyen, while also providing critical clinical support through patient examinations and the management of lab and imaging orders. Dr. Tran’s contributions are essential to our research success, and his expertise continues to grow with each trial.
Chief Executive Officer, Co-Founder
Lumi Research is led by CEO Bhavin, a biochemist with a profound commitment to improving patient outcomes through expanded clinical trial access. His experience as part of the scientific team that created venetoclax underscores his dedication to medical innovation. Inspired by his entrepreneurial family, Bhavin co-founded Lumi Research in 2021 to bridge the gap between cutting-edge research and community healthcare. His vision is to strategically grow Lumi Research, enabling more patients to benefit from life-saving treatment options close to home.
Chief Technology Officer
Jonathan has worked for several years at #1 cancer center in the world, developing software to manage clinical trials. As the burden of organizational constraints grew, he moved on to work with oncology startups to help better the software used in medical institutions. He has lead software projects in several different fields with many people all over the world. Overall he has 20+ years software development and management experience.
Chief Strategy Officer
Linda is a clinical research professional with over 25 years in healthcare serving in varied progressive roles. She has a history of optimizing clinical research infrastructures, orchestrating successful multi-institutional academic clinical research consortiums, and strategic pharmaceutical collaborations designed to decrease clinical trial activation timelines, strengthen quality assurance, and reduce financial operating associated costs.
Linda has provided clinical research operations oversight experience (first in man, phase I -III protocols, immune-modulating agents) for several major academic medical centers.
Late Chief Executive Officer, Co-Founder
Mike spent several years developing what is now the world most utilized clinical trial platform at the University of Texas, MD Anderson Cancer Center. There he served as the PI for multiple trials, and streamlined more than 3500 through his clinical trial management system. Mike has passed on now, but will live in our hearts forever. In honor of Mike, on May 10, 2021 the members of PRO Research Management unanimously voted to change the name to Lumi Research to symbolize the path he lit forward for the company.
Chief Operating Officer
With 20+ years of experience in the medical field, Lauren joined Lumi with one goal in mind; to propel Lumi Research towards success. Working alongside our late CEO, she trained, developed and managed a large clinical research team and oversaw the execution of over 100 clinical trials for one of the top cancer centers in the nation. Lauren’s focus is to ensure that Lumi Research is staffed with a passionate, talented and innovative team.
Business Development Manager
Clinical Research Coordinator II
Regulatory Specialist
Clinical Research Supervisor
Sr. Clinical Research Coordinator
Clinical Trial Assistant
Research Nurse
Principal Investigator | Oncologist, Hematologist
Dr. Nguyen has been a vital asset to Lumi Research since November 2024, bringing extensive expertise and a strong commitment to expanding access to oncology trials. He currently serves as Principal Investigator (Pl) on 6 studies (including 2 non-oncology) and has a proven track record, with prior experience as an investigator on 7 additional oncology trials and a history of successful patient enrollment.
Dr. Nguyen’s passion for ensuring equitable access to cutting-edge oncology research, coupled with his multi-state board certifications, including Texas, positions him as a key driver of our clinical research initiatives.
Network Investigator | Oncologist, Hematologist
With a legacy of service to both his country and his patients, Dr. Zaleski is expanding his community oncology practice to include clinical trials. A US Navy Captain (retired) and a physician who opened his practice in 1978, Dr. Zaleski’s longstanding affiliation with The Methodist Hospital group speaks to his expertise and commitment to quality care. His initiative to integrate clinical research reflects his forward-thinking approach and his unwavering dedication to providing his patients with access to the latest advancements in cancer treatment.
Investigator | Oncologist, Hematologist
Dr. Li, a respected community oncologist with a distinguished background from MD Anderson Cancer Center, is partnering with Lumi Research to enhance patient care in Garland, Texas. Since 2002, he has been dedicated to providing personalized treatment, and now, he is expanding his services to include clinical trials. This collaboration will bring groundbreaking treatment options directly to his community, reflecting his unwavering commitment to improving patient outcomes.
Investigator | Family Medicine
Lumi Research is strengthened by the addition of Dr. Alan Tran, whose primary objective is to optimize the patient research visit experience. Leveraging his background as a former private practice owner (sold to Village Medical), Dr. Tran brings both a strategic business perspective and a commitment to clinical excellence.
He plays a vital role in coordinating with the study team and remote Principal Investigator, Dr. David Nguyen, while also providing critical clinical support through patient examinations and the management of lab and imaging orders. Dr. Tran’s contributions are essential to our research success, and his expertise continues to grow with each trial.
Chief Executive Officer, Co-Founder
Lumi Research is led by CEO Bhavin, a biochemist with a profound commitment to improving patient outcomes through expanded clinical trial access. His experience as part of the scientific team that created venetoclax underscores his dedication to medical innovation. Inspired by his entrepreneurial family, Bhavin co-founded Lumi Research in 2021 to bridge the gap between cutting-edge research and community healthcare. His vision is to strategically grow Lumi Research, enabling more patients to benefit from life-saving treatment options close to home.
Chief Technology Officer
Jonathan has worked for several years at #1 cancer center in the world, developing software to manage clinical trials. As the burden of organizational constraints grew, he moved on to work with oncology startups to help better the software used in medical institutions. He has lead software projects in several different fields with many people all over the world. Overall he has 20+ years software development and management experience.
Chief Strategy Officer
Linda is a clinical research professional with over 25 years in healthcare serving in varied progressive roles. She has a history of optimizing clinical research infrastructures, orchestrating successful multi-institutional academic clinical research consortiums, and strategic pharmaceutical collaborations designed to decrease clinical trial activation timelines, strengthen quality assurance, and reduce financial operating associated costs.
Linda has provided clinical research operations oversight experience (first in man, phase I -III protocols, immune-modulating agents) for several major academic medical centers.
Late Chief Executive Officer, Co-Founder
Mike spent several years developing what is now the world most utilized clinical trial platform at the University of Texas, MD Anderson Cancer Center. There he served as the PI for multiple trials, and streamlined more than 3500 through his clinical trial management system. Mike has passed on now, but will live in our hearts forever. In honor of Mike, on May 10, 2021 the members of PRO Research Management unanimously voted to change the name to Lumi Research to symbolize the path he lit forward for the company.
Chief Operating Officer
With 20+ years of experience in the medical field, Lauren joined Lumi with one goal in mind; to propel Lumi Research towards success. Working alongside our late CEO, she trained, developed and managed a large clinical research team and oversaw the execution of over 100 clinical trials for one of the top cancer centers in the nation. Lauren’s focus is to ensure that Lumi Research is staffed with a passionate, talented and innovative team.
Business Development Manager
Clinical Research Coordinator II
Regulatory Specialist
Clinical Research Supervisor
Sr. Clinical Research Coordinator
Clinical Trial Assistant
Research Nurse
